Related Experiment Video
Updated: Dec 24, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Nontuberculous mycobacterial infections in left ventricular assist device patients
Christopher Radcliffe1, Natnael Doilicho1, Matthew Grant1,2
1Yale School of Medicine, New Haven, Connecticut.
Abstract:
Left ventricular assist devices (LVADs) are integral for the management of medically refractory heart failure, and LVAD infections are common following device placement. Most infections are caused by Staphylococcal spp. and Gram-negative enteric bacteria but nontuberculous mycobacterial (NTM) infections have been reported. We present the second-ever reported case of a driveline infection caused by Mycobacterium fortuitum in a 75-year-old male with a continuous-flow LVAD. After receiving meropenem, azithromycin, and ciprofloxacin, he underwent device exchange and ultimately died after failing to recover neurologically. Management of NTM infections presents a clinical challenge due to the propensity for rapidly growing mycobacterial species to form biofilms and the possibility of negative cultures delaying diagnosis. To address the literature gap surrounding NTM infections in LVAD patients, we performed a systematic review and present all previously reported cases.
Insights
Nontuberculous mycobacterial (NTM) infections, like Mycobacterium fortuitum, pose a rare but serious challenge in left ventricular assist device (LVAD) patients. This case highlights diagnostic difficulties and the need for further research into effective NTM infection management in LVAD recipients.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Device Technology
Background:
- Left ventricular assist devices (LVADs) are critical for end-stage heart failure management.
- LVAD infections are a significant complication, with Staphylococcal and Gram-negative bacteria being common culprits.
- Nontuberculous mycobacterial (NTM) infections are an infrequent but reported complication.
Observation:
- This report details a rare case of a driveline infection caused by Mycobacterium fortuitum in a 75-year-old male LVAD recipient.
- The patient received a combination of meropenem, azithromycin, and ciprofloxacin.
- Despite device exchange, the patient experienced a fatal neurological decline.
Findings:
- Mycobacterium fortuitum, a rapidly growing NTM species, can cause challenging LVAD driveline infections.
- NTM infections are difficult to diagnose due to biofilm formation and potential for negative cultures.
- This case represents the second reported instance of Mycobacterium fortuitum driveline infection in an LVAD patient.
Implications:
- Effective management strategies for NTM infections in LVAD patients are urgently needed.
- Early and accurate diagnosis of NTM infections is crucial for improved patient outcomes.
- Further research is required to address the literature gap concerning NTM infections in LVAD populations.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Endocarditis III: Medical Management
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

